JSR Life Sciences Enters Definitive Agreement to Transfer Crown Bioscience to Adicon Holdings Limited
Strategic Transaction Positions Crown Bioscience for Accelerated Growth in Translational Oncology SAN DIEGO–(BUSINESS WIRE)–JSR Life Sciences LLC (“JSR... Read more.
Flipping the script: Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity
$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from... Read more.
Europe Must Embrace Long Duration Energy Storage to Manage Costs and Meet Climate Goals: New Report
Providing greater revenue certainty for long duration energy storage will save grid operating and curtailment costs, avoid stranded assets, and enable energy independence... Read more.
CLEAN Linen & Workwear Reduces Collisions by 38% with Samsara
Data-led driver coaching programme delivers measurable results in road safety and operational efficiency LONDON–(BUSINESS WIRE)–UK linen and workwear... Read more.
JFrog Exposes Enterprise AI Blind Spots, Driving Centralized Software Supply Chain Governance
New Shadow AI Detection capability enables transparency and risk management, guarding against uncontrolled use of AI models and API calls SUNNYVALE, Calif. &... Read more.
PPG and FIRE-OFF launch packaging recycling program in the Netherlands
Sigma EcoCollect initiative supports PPG’s sustainability, circular economy goals AMSTERDAM–(BUSINESS WIRE)–PPG (NYSE: PPG) today announced that the... Read more.
Virometix AG Announces Completion of $15 Million Financing Round to Advance Development of V-212 and Next-Generation Synthetic Vaccines
SCHLIEREN, Switzerland–(BUSINESS WIRE)–Virometix AG, a clinical-stage biotechnology company pioneering fully synthetic vaccines, today announced the... Read more.
Black Hat Europe 2025 Summits to Expose Critical AI Threats, Nation-State Attacks, and Financial Sector Vulnerabilities
Summit programming will feature three full-day Summits, including the inaugural Financial Services Security Summit and AI Security Summit LONDON–(BUSINESS... Read more.
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
Following FDA clearance for confirmatory Phase 3 trial TELLOMAK-3, lacutamab is progressing toward Phase 3 initiation in H1 2026 and potential accelerated approval... Read more.
Ionis Prices Convertible Notes Offering to Refinance 2026 Convertible Notes
– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 Convertible Notes prior to or at maturity CARLSBAD, Calif.–(BUSINESS... Read more.